What are the CURB-65 criteria and how to apply them? | Rounds What are the CURB-65 criteria and how to apply them? | Rounds
Loading...

What are the CURB-65 criteria and how to apply them?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2026 · View editorial policy

CURB‑65 Severity Assessment for Community‑Acquired Pneumonia

CURB‑65 assigns one point for each of five variables: new confusion, urea > 7 mmol/L, respiratory rate ≥ 30 breaths/min, systolic blood pressure < 90 mm Hg or diastolic ≤ 60 mm Hg, and age ≥ 65 years [1].
Total scores stratify patients into low (0‑1), intermediate (2), and high (3‑5) risk categories and are commonly used to help decide site‑of‑care [2].

Component Definitions

  • Confusion: Altered mental status (e.g., new disorientation).
  • Urea: Blood urea nitrogen > 19 mg/dL (≈ 7 mmol/L).
  • Respiratory Rate: ≥ 30 breaths per minute.
  • Blood Pressure: Systolic < 90 mm Hg or diastolic ≤ 60 mm Hg.
  • Age: ≥ 65 years.
    Each present variable contributes one point [1].

Scoring Algorithm

CURB‑65 Score Suggested Management
0–1 Outpatient treatment; oral amoxicillin or doxycycline are reasonable options [3].
2 Consider short inpatient stay or observation unit; intravenous antibiotics may be used if comorbidities are present [4].
≥3 Hospital admission; ICU assessment may be needed for scores ≥ 4; intravenous broad‑spectrum therapy is typical [4].

Evidence Supporting Risk Stratification

  • The original CURB‑65 validation reported 30‑day mortality of roughly 1 % for scores 0–1, about 9 % for score 2, and around 22 % for scores ≥ 3 [1].
  • A rapid evidence synthesis of reviews noted that higher CURB‑65 scores are associated with increased mortality and more frequent need for hospitalization [2].

Therapeutic Considerations

  • Low‑risk (0–1): Oral monotherapy (e.g., amoxicillin) is generally sufficient and has been shown to result in high discharge rates in retrospective cohorts [3].
  • Intermediate‑risk (2): Combination therapy (β‑lactam plus macrolide or respiratory fluoroquinolone) is often recommended to reduce the risk of treatment failure, as observed in observational studies [4].
  • High‑risk (≥3): Dual intravenous therapy is recommended in guideline‑based pathways for severe CAP [4].

Practical Tips for Using CURB‑65

  • Calculate the score at the initial assessment of suspected CAP.
  • Obtain a urea measurement promptly (point‑of‑care or laboratory) to avoid missing this component.
  • Document mental status with a simple scale (e.g., GCS) before assigning the confusion point.
  • Verify vital signs; repeat if initial values are borderline.
  • Be cautious in patients with chronic renal impairment where urea may be chronically elevated—interpret the score in the clinical context.

Common Pitfalls

  • Omitting the urea measurement can lead to under‑scoring and inappropriate outpatient discharge.
  • Misclassifying diastolic blood pressure ≤ 60 mm Hg as normal may miss a point.
  • Applying CURB‑65 without considering severe immunosuppression or other comorbidities may underestimate severity.

These criteria offer a rapid, evidence‑based tool to stratify pneumonia severity and guide disposition and antimicrobial selection.

Related Questions